These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

933 related items for PubMed ID: 12444551

  • 1. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM, Lallemand F, Balkenende A, Verwoerd D, Michalides R.
    Oncogene; 2002 Nov 21; 21(53):8158-65. PubMed ID: 12444551
    [Abstract] [Full Text] [Related]

  • 2. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R, Finney GL, Carroll JS, Lee CS, Musgrove EA, Sutherland RL.
    Cancer Res; 2002 Dec 01; 62(23):6916-23. PubMed ID: 12460907
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL.
    Cancer Res; 2002 Jun 01; 62(11):3126-31. PubMed ID: 12036924
    [Abstract] [Full Text] [Related]

  • 4. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest.
    Dhillon NK, Mudryj M.
    Oncogene; 2002 Jul 11; 21(30):4626-34. PubMed ID: 12096339
    [Abstract] [Full Text] [Related]

  • 5. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C, Chattopadhyay A, Parkhurst C, Yang E.
    Oncogene; 2002 Nov 07; 21(51):7765-75. PubMed ID: 12420213
    [Abstract] [Full Text] [Related]

  • 6. Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain.
    Varma H, Conrad SE.
    Oncogene; 2000 Sep 28; 19(41):4746-53. PubMed ID: 11032025
    [Abstract] [Full Text] [Related]

  • 7. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL.
    J Biol Chem; 1997 Apr 18; 272(16):10882-94. PubMed ID: 9099745
    [Abstract] [Full Text] [Related]

  • 8. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ, Jordan VC.
    Cancer Res; 1996 May 15; 56(10):2321-30. PubMed ID: 8625307
    [Abstract] [Full Text] [Related]

  • 9. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens.
    Wilcken NR, Prall OW, Musgrove EA, Sutherland RL.
    Clin Cancer Res; 1997 Jun 15; 3(6):849-54. PubMed ID: 9815758
    [Abstract] [Full Text] [Related]

  • 10. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells.
    Foster JS, Wimalasena J.
    Mol Endocrinol; 1996 May 15; 10(5):488-98. PubMed ID: 8732680
    [Abstract] [Full Text] [Related]

  • 11. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM, Dickson RB.
    Oncogene; 2001 Jul 27; 20(33):4554-67. PubMed ID: 11494151
    [Abstract] [Full Text] [Related]

  • 12. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
    Sweeney KJ, Swarbrick A, Sutherland RL, Musgrove EA.
    Oncogene; 1998 Jun 04; 16(22):2865-78. PubMed ID: 9671407
    [Abstract] [Full Text] [Related]

  • 13. 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells.
    Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, Truss M, Beato M, Sica V, Bresciani F, Weisz A.
    Oncogene; 1996 Jun 06; 12(11):2315-24. PubMed ID: 8649771
    [Abstract] [Full Text] [Related]

  • 14. DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle.
    Dees C, Askari M, Foster JS, Ahamed S, Wimalasena J.
    Mol Carcinog; 1997 Feb 06; 18(2):107-14. PubMed ID: 9049186
    [Abstract] [Full Text] [Related]

  • 15. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL.
    Mol Endocrinol; 1995 Dec 06; 9(12):1804-13. PubMed ID: 8614416
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.
    Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM.
    Proc Natl Acad Sci U S A; 2000 Aug 01; 97(16):9042-6. PubMed ID: 10908655
    [Abstract] [Full Text] [Related]

  • 17. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
    Sasano H, Frost AR, Saitoh R, Taniyama Y, Nagura H, Matsunaga G, Takehana K, Kimura M, Silverberg SG.
    Anticancer Res; 1997 Aug 01; 17(5A):3685-90. PubMed ID: 9413224
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
    Srethapakdi M, Liu F, Tavorath R, Rosen N.
    Cancer Res; 2000 Jul 15; 60(14):3940-6. PubMed ID: 10919672
    [Abstract] [Full Text] [Related]

  • 19. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H, Iavarone A, LaBaer J, Reeves SA.
    Oncogene; 1997 May 29; 14(21):2533-42. PubMed ID: 9191053
    [Abstract] [Full Text] [Related]

  • 20. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.
    Prall OW, Rogan EM, Musgrove EA, Watts CK, Sutherland RL.
    Mol Cell Biol; 1998 Aug 29; 18(8):4499-508. PubMed ID: 9671459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.